ADVICENNE
Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.
ADVICENNE
Social Links:
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2007-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.advicenne.com
Total Employee:
11+
Status:
Active
Contact:
+33 (0)1 85 73 36 20
Total Funding:
63.39 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps Global Site Tag
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
AskGene Pharma
AskGene Pharma is a pharmaceuticals company.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
SciClone Pharmaceuticals
SciClone Pharmaceuticals is a pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Advicenne
BNP Paribas
BNP Paribas investment in Post-IPO Debt - Advicenne
Bpifrance
Bpifrance investment in Post-IPO Debt - Advicenne
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Advicenne
IXO Private Equity
IXO Private Equity investment in Private Equity Round - Advicenne
Cemag Invest
Cemag Invest investment in Private Equity Round - Advicenne
IRDI
IRDI investment in Venture Round - Advicenne
InnoBio
InnoBio investment in Private Equity Round - Advicenne
Bpifrance
Bpifrance investment in Private Equity Round - Advicenne
InnoBio Fund
InnoBio Fund investment in Venture Round - Advicenne
Official Site Inspections
http://www.advicenne.com Semrush global rank: 2.43 M Semrush visits lastest month: 7.77 K
- Host name: cluster026.hosting.cdn.ovh.net
- IP address: 46.105.204.26
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Advicenne"
Advicenne - Crunchbase Company Profile & Funding
Advicenne reported a 9.2% increase in gross sales for 2024, reaching €4.8 million, driven by Sibnayal® with a 14% increase in sales. The company also reached a significant milestone …See details»
Org Chart Advicenne - The Official Board
Organizational Chart of Advicenne. Advicenne www.advicenne.com. has 14 executives +33 466 055 420; Add an executive. Advicenne (ADVIC) News . Anything missing? We search for you. …See details»
Advicenne Management Team | Org Chart - RocketReach
Top Advicenne Management Employees Didier Laurens Chief Executive Officer at Advicenne Paris, FR View. 2 groupama-am.fr; advicenne.com; 5 3314213XXXX; 35121390XXXX; …See details»
Advicenne - Org Chart, Teams, Culture & Jobs | The Org
View Advicenne's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Contact Us - Advicenne
Advicenne SA. 262 Rue du Faubourg Saint Honoré 75008 PARIS – FRANCE Phone : +33 (0)1 85 73 36 20See details»
Advicenne (75008) : siret, siren, TVA, adresse... - Annuaire Entreprises
19/05/2023 Convocation aux assemblées. Source : Descriptif : Dénomination : ADVICENNE. Siren : 497587089. ADVICENNE Societé anonyme au capital de 1.991.430,20 euros Siège …See details»
ADVICENNE | Chiffre d'affaires, résultat, bilans
Trouvez les informations financières et légales sur ADVICENNE à PARIS 8. Coordonnées, comptes, bilans, SIRET, TVA, Kbis, actes, statuts, marques, dirigeant.See details»
AVANZANITE BIOSCIENCE PARTNERS WITH ADVICENNE TO …
Feb 28, 2023 ABOUT ADVICENNE: Advicenne (Euronext: ALDVI) is a specialty pharmaceutical company founded in 2007, specializing in the development of innovative treatments in …See details»
Our Story - Advicenne
For more than 10 years, Advicenne has been dedicated to developing innovative, effective and safe treatments for people living with rare renal diseases who have very limited therapeutic …See details»
Advicenne provides an update on its activities following
Jun 15, 2021 Advicenne David Solomon, Chairman Didier Laurens, CEO +33 (0)4 66 05 54 20 Email: [email protected] NewCap Financial communications Dusan Oresansky, …See details»
Potassium citrate/Potassium bicarbonate - Drug Targets, …
Jan 23, 2025 Advicenne agreement further validates Avanzanite’s unique business model and establishes it as the go-to commercialization partner for medicines treating rare diseases …See details»
Le Conseil d'Administration - Advicenne
Didier a rejoint Advicenne en tant que DG en mai 2021 et a ensuite assumé le rôle de directeur financier. Didier possède une vaste expérience dans les secteurs de la finance et de la santé, …See details»
Advicenne Announces its 2025 Financial Calendar - Yahoo Finance
PARIS, November 28, 2024--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and …See details»
au capital de 1 991 430,20 euros Siège social - Advicenne
Le 6 mars 2023, Advicenne annonce le remboursement et le lancement commercial de Sibnayal® au Danemark. Le 14 juin 2023, Advicenne annonce la présentation des derniers résultats à …See details»
Advicenne Announces Positive Pivotal Phase III Clinical Data for ...
Sep 11, 2017 Advicenne LA Granier, S Delbaere, J Rachline [email protected] +33 (0)4 66 05 54 20 Citigate Dewe Rogerson David Dible, Sylvie Berrebi, Marine Perrier [email protected] +44 …See details»
Didier Laurens Directeur Général Advicenne : "On est presque …
Oct 16, 2024 REPLAY avec Didier Laurens Directeur Général Advicenne : LIVE diffusé le 13 septembre 2023 à 12h sur www.labourseetlavie.com; Didier Laurens Directeur Général …See details»
Advicenne achieves major milestones in the US thanks to several ...
PARIS, October 01, 2024--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and …See details»
FAQ Investisseurs - Advicenne
For more than 10 years, Advicenne has been dedicated to developing innovative, effective and safe treatments for people living with rare renal diseases who have very limited therapeutic …See details»
Government of Canada announces the organization to establish …
1 day ago Today, the Honourable Kamal Khera, Minister of Health, announced over $6.3 million in funding over five years for the Sinneave Family Foundation to establish and lead the new …See details»
Événements & présentations - Advicenne
Advicenne 262, Rue du Faubourg Saint Honoré 75008 Paris – FRANCE Telephone: +33 (0)1 85 73 36 20 Fax : +33 (0)1 85 73 36 29 E-mail: [email protected]See details»